Global Personalized Cell Therapy Market to Perceive Substantial Growth During 2018–2026
The
patient-tailored therapies for the treatment of variety of disease
are known as personalized cell therapy. The personalized cell therapy
is based on genomic profile, and disease prevalence/severity and the
drug developed by this therapy target the patients who matches the
specific disease physiopathology and/or patient characteristics.
The
personalized cell therapy is mainly developed for the treatment of
high unmet need disease such as cancer, also it comprises drugs for
treatment of other diseases such as autoimmune disease,
cardiovascular, neurologic and inflammatory disease.
Personalized
cell therapy also finds application in the area of platelet
transfusions, packed red cell transfusions, bone marrow
transplantation and in organ transplantation.
Request
For Sample Copy of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/204
Personalized
Cell Therapy Market Dynamics
The
continuous development in science and technology sector has led to
development of various novel individualized drugs, which would fuel
growth of the personalized cell therapy market in the near future.
Personalized cell therapy favors the accurate diagnosis of the
disease and active monitoring of the treatment response and disease
progression. This allows for early detection of diseases at molecular
level and enables the physician to prepare the treatment regime for
the specific patient requirement. This helps the patient recover at a
significant pace and also helps avoid any major side effects, as
individualized cell therapy is based on patient’s genomics.
Newly
introduced procedures and techniques are expected to favor increase
in adoption rate for personalized cell therapy in the near future.
New ventures in the biologics industry are expected to be a major
push for the market to grow, for instance, a high demand for
biological compounds is influencing organizations to manufacture
products using the biopharmaceutical process, which is further
administered through injections.
Large
untapped markets in emerging economies can be capitalized upon
through favorable product pricing, which further can facilitate the
increase in number of procedures worldwide. Also, as the
manufacturing cost requirement is low in emerging economies as
compare to developed countries this will help to grow the market in
emerging economies such as India and China.
Key
features of the study:
-
This report provides in-depth analysis of the personalized cell therapy market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2024)
-
It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline drugs, regional outlook, and competitive strategy adopted by the leading players
-
It profiles leading players in the global personalized cell therapy market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
-
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
Detailed
Segmentation:
-
Global Personalized Cell Therapy Market, By Applications:
-
Platelet Transfusions
-
Bone Marrow Transplantation
-
Packed Red Cell Transfusions
-
Organ Transplantation
-
Increased
economic burden due to neurological disorders expected to fuel the
growth in personalized cell therapy market
In
complicated neurological disorders such as multiple sclerosis, stroke
or spinal cord injuries, scientist claim that stem cells treatment
may be the best option or choice of cure. Stem cells can be replaced
with damaged cells or the cells, which are highly mitigated to immune
responses even in the central nervous system. There are no successful
clinical trials so far, as the scientists are facing hurdles in stem
cell therapies, however, the use of embryonic stem cells is still a
moral issue in most of the regions, obtaining adult stem cells is
difficult to collect or tough to be expanded in a therapeutically
sufficient amount.
Some
of the major companies in personalized cell therapy market are Cytori
Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL
Therapeutics, Inc., MolMed S.p.A. and Vericel Corporation.
About
Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Comments
Post a Comment